Myasthenia Gravis and COVID-19: Clinical Characteristics and Outcomes

Myasthenia gravis (MG), an autoimmune neuromuscular disorder, may be a risk factor for severe COVID-19. We conducted an observational retrospective study with 15 consecutive adult MG patients admitted with COVID-19 at four hospitals in São Paulo, Brazil. Most patients with MG hospitalized for COVID-...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Neurol
Auteurs principaux: Camelo-Filho, Antonio E., Silva, André M. S., Estephan, Eduardo P., Zambon, Antônio A., Mendonça, Rodrigo H., Souza, Paulo V. S., Pinto, Wladimir B. V. R., Oliveira, Acary S. B., Dangoni-Filho, Iron, Pouza, Ana F. P., Valerio, Berenice C. O., Zanoteli, Edmar
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2020
Sujets:
Neurology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7516054/
https://ncbi.nlm.nih.gov/pubmed/33013676
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2020.01053
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires